Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

Medical Properties Trust (NYSE:MPT) Announces Earnings Results

Medical Properties Trust logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Medical Properties Trust reported $0.11 in quarterly EPS, missing the $0.13 consensus estimate, while revenue increased 5.3% year over year to $250.14 million. The company still posted a negative net margin and negative return on equity.
  • MPT completed a $2.4 billion secured-debt refinancing, capturing approximately $123 million in net discounts and aiming to eliminate debt maturities until June 2028.
  • Tenant and rent-collection challenges remain significant: HSA operations are improving, but rent payments have not resumed, and MPT agreed to reduce Priory’s annual rent by about 18%. Analysts maintain a consensus “Sell” rating with a $4.15 price target.
  • MarketBeat previews top five stocks to own in November.

Medical Properties Trust (NYSE:MPT - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.02), Zacks reports. The business had revenue of $250.14 million for the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. The firm's revenue was up 5.3% compared to the same quarter last year.

Here are the key takeaways from Medical Properties Trust's conference call:

  • Annualized cash rental revenue has surpassed $1 billion despite approximately $600 million of property sales, and management expects cash rents to remain above that level in 2027.
  • MPT completed a $2.4 billion secured-debt refinancing, capturing approximately $123 million in net discounts, and expects its next financing steps to eliminate maturities until June 2028 while increasing covenant and secured-financing flexibility.
  • HSA’s hospitals reportedly showed improving operations, with overall volume up 14%, surgeries up 33%, and cash collections up 24% since August; however, MPT has not projected when rent payments will resume because billing and collection problems remain unresolved.
  • MPT agreed to reduce Priory’s annual rent by approximately 18% amid U.K. NHS budget constraints, although the agreement includes potential rent recovery as revenue improves, stronger parent-company credit support, and a potential lease extension through 2055.
  • Management highlighted strong performance across several major operators, including MEDIAN, Circle Health, Swiss Medical Network, IMED, Ernest Health, and NOR; NOR is expected to resume paying 100% of contractual rent in December.

Medical Properties Trust Price Performance

Shares of NYSE MPT traded down $0.31 during mid-day trading on Thursday, reaching $2.44. The company's stock had a trading volume of 35,722,169 shares, compared to its average volume of 7,730,057. The stock has a 50-day moving average of $3.49 and a two-hundred day moving average of $4.38. The stock has a market capitalization of $1.46 billion, a P/E ratio of -40.67 and a beta of 1.45. The company has a debt-to-equity ratio of 2.16, a quick ratio of 3.12 and a current ratio of 3.12. Medical Properties Trust has a 1-year low of $2.35 and a 1-year high of $6.47.

Medical Properties Trust Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 8th. Stockholders of record on Thursday, September 10th were issued a dividend of $0.09 per share. The ex-dividend date of this dividend was Thursday, September 10th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 14.8%. Medical Properties Trust's dividend payout ratio is presently -600.00%.

Wall Street Analyst Weigh In

MPT has been the subject of a number of recent research reports. Weiss Ratings lowered Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 18th. Wells Fargo & Company decreased their price target on Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating for the company in a report on Tuesday, September 1st. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Sell" and a consensus target price of $4.15.

View Our Latest Report on Medical Properties Trust

Trending Headlines about Medical Properties Trust

Here are the key news stories impacting Medical Properties Trust this week:

Medical Properties Trust Company Profile

(Get Free Report)

Medical Properties Trust, Inc is a healthcare-focused real estate investment trust (REIT) that owns and invests in healthcare facilities. Its portfolio has historically included hospitals, inpatient rehabilitation facilities, long-term acute-care hospitals, behavioral health facilities and other properties used by healthcare providers.

Founded in 2003 and headquartered in Birmingham, Alabama, the company primarily generates income by leasing properties to healthcare operators under long-term agreements.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines